Of course the purpose matters. Drugs have Health Canada approved indications. If a medicine was prescribed and was not covered by the ODB, than your physician prescribed it off-label. It is unfortunate, but the ODB should absolutely not be covering off-label use as it opens up a huge can of worms with respect to liability and abuse.
That is a little talked about issue when it comes to generic manufacturers. Frequently, they do not have a consistent supply like branded manufacturers and in some jurisdictions, governments tender increasing the risk of shortages. The solution is to ensure there are multiple suppliers, even if it means paying more to get supply from the branded manfuacturer.Blanche123 wrote: ↑May 1st, 2017 3:07 pmI have another prescription that was written in the late fall but the meds are on the shortage list and will not be available until perhaps May - if then since they were supposed to be available in early March. By the time the medication is available, depending on the cost of it, I would probably be better off just paying for it since the annual $100 is due in Aug. No point paying twice.